Ketone reductase activity and reduced haloperidol/haloperidol ratios in haloperidol-treated schizophrenic patients-Reference-Cited by-同舟云学术

Ketone reductase activity and reduced haloperidol/haloperidol ratios in haloperidol-treated schizophrenic patients

Published:1995-07 Issue:2 Volume:57 Page:101-108
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Huang Huang-Fuh,Jann Michael W.,Tseng Yung-Te,Chung Ming-Cheng,Chien Ching-Piao,Chang Wen-Ho

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference26 articles.

1. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin;Bertilsson;Clin Pharmacol Ther,1992

2. Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D2 receptors;Bowen;Eur J Pharmacol,1990

3. Recent developments in hepatic drug oxidation: implications for clinical pharmacokinetics;Brosen;Clin Pharmacokinet,1990

4. Preliminary behavioral and pharmacologic studies on the haloperidol metabolite reduced haloperidol;Browning;Society for Neuroscience Abstracts,1982

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of warfarin and warfarin alcohols in dried blood spots by ultra-high performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS);Microchemical Journal;2018-01

2. Reduced haloperidol does not interfere with the antipsychotic activity of haloperidol in the treatment of acute schizophrenia;International Clinical Psychopharmacology;1999-07

3. High-performance liquid chromatographic methods for the analysis of haloperidol and chlorpromazine metabolism in vitro by purified cytochrome P450 isoforms;Journal of Chromatography B: Biomedical Sciences and Applications;1998-11

4. Metabolism of Haloperidol and Its Tetrahydropyridine Dehydration Product HPTP;Drug Metabolism Reviews;1998-01

5. Blood levels of reduced halopertool versus clinical efficacy and extrapyramidal side effects of haloperidol;Progress in Neuro-Psychopharmacology and Biological Psychiatry;1997-02